MedPath

A comparison of effects of ultrasound guided intermediate cervical plexus block and local anaesthetic infiltration for perioperative analgesia and introperative hemodynamic stability in patients undergoing retromastoid suboccipital craniotomy

Phase 3
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2022/07/044429
Lead Sponsor
Nizams Institute of Medical Sciences
Brief Summary

This is a prospective randomized controlled trail comparing the effect of ultrasound guided intermediate cervical plexus block and scalp block versus local anesthetic infiltration and scalp block on hemodynamic response and peri operative analgesia in patients umdergoing excision of cerebellopontine angle tumors with retromastoid suboccipital craniotomy. Total of 60 patients will be recruited with 30 in each group, group C - patients recieving ultra sound guided intermediate cervical plexus block and scalp block and group I - patients receiving local anaesthetic infiltration and scalp block.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

1)Patients aged between 18 to 60YEARS 2)Patients of both gender 3)Patients with ASA grade 1 and 2 4)Patients with Weight 40 to 80kg 5)Patients with any CP angle tumor with GCS-15.

Exclusion Criteria

1)Patients with known respiratory and cardiac problems 2)Patients with Congenital Diaphragmatic problems 3)Local sepsis 4)Bleeding diathesis 5)Hypersensitivity to local anaesthetics 6)Duration of surgery more than 4 hours.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamics at pin insertion, skin incision and dural opening1 year
Secondary Outcome Measures
NameTimeMethod
Post operative analgesia as assessed by visual Analogue Scale,SpO2, EtCO2, entropy

Trial Locations

Locations (1)

Nizams Institute of Medical Sciences

🇮🇳

Hyderabad, TELANGANA, India

Nizams Institute of Medical Sciences
🇮🇳Hyderabad, TELANGANA, India
Kandala Harika
Principal investigator
9618076075
harika.kandala@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.